α-2-Macroglobulin induces the shedding of microvesicles from cutaneous wound myofibroblasts.


Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
07 2019
Historique:
received: 16 10 2018
accepted: 31 10 2018
pubmed: 28 11 2018
medline: 8 5 2020
entrez: 28 11 2018
Statut: ppublish

Résumé

Microvesicles (MVs) are recognized as an important class of cell-to-cell messengers. Although the properties of MVs are increasingly documented, the mechanisms regulating MV biogenesis remain debated. Myofibroblasts are a key cellular component of wound healing and have been shown to produce MVs upon stimulation with serum. However, the mediator(s) responsible for the observed effect of serum on MV release have yet to be identified. To isolate the molecule(s) of interest, serum proteins were sequentially separated using chromatography, selective precipitation, and electrophoresis. MV production was assessed throughout the purification and after stimulation of myofibroblasts with two potent purified molecules. α-2-Macroglobulin (A2M) was thereby found to dose-dependently stimulate MV release. We confirmed the presence of the A2M receptor, low-density lipoprotein receptor-related protein-1 (LRP1), on myofibroblasts. Inhibition of LRP1 resulted in a significant decrease in MV production. Together, our results suggest that A2M positively regulates MV shedding through the activation of LRP1 on myofibroblasts.

Identifiants

pubmed: 30479021
doi: 10.1002/jcp.27794
doi:

Substances chimiques

LRP1 protein, human 0
Low Density Lipoprotein Receptor-Related Protein-1 0
Pregnancy-Associated alpha 2-Macroglobulins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11369-11379

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Alexandra Laberge (A)

Centre de Recherche en Organogenèse Expérimentale de l'Université Laval (LOEX), Quebec, QC, Canada.
Centre de Recherche du CHU de Quebec-Université Laval, Quebec, QC, Canada.

Akram Ayoub (A)

Centre de Recherche en Organogenèse Expérimentale de l'Université Laval (LOEX), Quebec, QC, Canada.
Centre de Recherche du CHU de Quebec-Université Laval, Quebec, QC, Canada.

Syrine Arif (S)

Centre de Recherche en Organogenèse Expérimentale de l'Université Laval (LOEX), Quebec, QC, Canada.
Centre de Recherche du CHU de Quebec-Université Laval, Quebec, QC, Canada.

Sébastien Larochelle (S)

Centre de Recherche en Organogenèse Expérimentale de l'Université Laval (LOEX), Quebec, QC, Canada.
Centre de Recherche du CHU de Quebec-Université Laval, Quebec, QC, Canada.

Alain Garnier (A)

Department of Chemical Engineering, Faculty of Sciences and Engineering, Université Laval, Quebec, QC, Canada.

Véronique J Moulin (VJ)

Centre de Recherche en Organogenèse Expérimentale de l'Université Laval (LOEX), Quebec, QC, Canada.
Centre de Recherche du CHU de Quebec-Université Laval, Quebec, QC, Canada.
Department of Surgery, Faculty of Medicine, Université Laval, Quebec, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH